Skip to main content
Veterinary Medicines

OVASUIN

Authorised
  • HUMAN CHORIONIC GONADOTROPIN
  • Gonadotropin, equine, serum

Product identification

Medicine name:
OVASUIN
Active substance:
  • HUMAN CHORIONIC GONADOTROPIN
  • Gonadotropin, equine, serum
Target species:
  • Pig (female)
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • HUMAN CHORIONIC GONADOTROPIN
    1000.00
    international unit(s)
    /
    10.00
    millilitre(s)
  • Gonadotropin, equine, serum
    2000.00
    international unit(s)
    /
    10.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (female)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Pig (female)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG03GA99
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CZ Vaccines S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Ovejero S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3874 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."